During the last session, Adverum Biotechnologies Inc (NASDAQ:ADVM)’s traded shares were 0.8 million, with the beta value of the company hitting 0.88. At the end of the trading day, the stock’s price was $9.19, reflecting an intraday loss of -2.13% or -$0.2. The 52-week high for the ADVM share is $29.70, that puts it down -223.18 from that peak though still a striking 22.74% gain since the share price plummeted to a 52-week low of $7.10. The company’s market capitalization is $190.69M, and the average trade volume was 297.00K shares over the past three months.
Adverum Biotechnologies Inc (NASDAQ:ADVM) trade information
Adverum Biotechnologies Inc (ADVM) registered a -2.13% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.13% in intraday trading to $9.19, hitting a weekly high. The stock’s 5-day price performance is -18.96%, and it has moved by -37.31% in 30 days. Based on these gigs, the overall price performance for the year is 14.63%.
Adverum Biotechnologies Inc (ADVM) estimates and forecasts
Statistics show that Adverum Biotechnologies Inc has outperformed its competitors in share price, compared to the industry in which it operates. Adverum Biotechnologies Inc (ADVM) shares have gone down -7.17% during the last six months, with a year-to-date growth rate more than the industry average at 55.34% against 12.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 0.36%. While earnings are projected to return 48.81% in 2024.
ADVM Dividends
Adverum Biotechnologies Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
